1501 — Shanghai INT Medical Instruments Co Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$4.87bn
- HK$4.53bn
- CNY752.84m
- 92
- 22
- 64
- 66
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 112 | 137 | 156 | 144 | 175 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -21.7 | -13.2 | -38.7 | -17.7 | 0.113 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -16.8 | -50.2 | -74.4 | 16.6 | -44.6 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 92.1 | 95.7 | 72.8 | 180 | 178 |
Capital Expenditures | -74.1 | -78.5 | -299 | -288 | -231 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -39.7 | -143 | 30.7 | -28 | -52.6 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -114 | -222 | -268 | -316 | -284 |
Financing Cash Flow Items | 6.3 | 1.5 | 16.6 | -3.07 | -12.7 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 754 | -27.9 | -31.1 | 9.72 | 8.06 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 739 | -167 | -230 | -122 | -94.6 |